[MARKET ANALYSIS] European bourses trade on the backfoot ahead of US NFP; VOW3 GY approves Future Plan 2030
European bourses traded cautiously ahead of US jobs data, while Volkswagen surged on approving major restructuring cuts and US futures held mixed amid Lululemon's sharp pre-market drop.
News detail
European bourses start the final trading session of the week on the backfoot, albeit only modestly. Focus will be on the US jobs report, with NFP expected at 58k. Although this data point is key for the Fed, most policymakers will be focused on the inflation print expected in a week's time. In his remarks on Thursday, Fed's Waller commented that the labour market is in satisfactory shape, but put more emphasis on inflation, stating that he will support holding policy rate steady at September FOMC meeting if August inflation data shows continued progress. Sectors lack a clear bias. Tech tops the sector pile, with Travel & Leisure and Autos rounding out the sector gainers. To the downside is Media, following Vivendi earnings (see more below), with Chemicals and Banks following behind. The biggest story of the morning came from Volkswagen, after the Co.'s supervisory board approved a plan that would include an additional 50k job cuts. The carmaker is also targeting an operating margin of 9% by 2030. Focus for new CEO Blume has been on cost-cutting as he tries to make the Co. more efficient, nimble and profitable. Being able to push changes through Volkswagen, especially job cuts, is made difficult as 12 of 20 seats on the supervisory board are held by labour representatives and Lower Saxony. With the passage of this plan, it makes Blume's job easier. As a result, shares of VW are higher by 5.5%, while Porsche (+2.9%) is also benefiting. Other key movers: Vodafone (+1.8%), double upgrade to buy at Goldman Sachs; Vivendi (-3.9%), reported H1 revenue and EBIT that fell Y/Y; Neste (+2.2%), upgraded to buy at Goldman Sachs. US equity futures are mixed, with clear outperformance in the NQ. After-hours, Lululemon (-17.9% pre-market) reported poor metrics, in which revenue missed expectations, comparable sales declined, and the company sharply cut its Q3 and FY outlooks, citing weaker North American demand, inconsistent product response and a slow start to the current quarter.
Related stocks
2 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
